Organigram Provides Shareholder Update
OrganiGram Holdings Inc. (ACB:CSE) has provided an update to shareholders while reviewing milestones of 2014 and looking at the growth and goals of 2015.
Since the inception of OrganiGram in April, 2014, the company has been growing and developing at a very fast pace. Through this growth, there have been some tremendous achievements, which include receiving its organic certification, producing its first crops, listing of shares on the TSX Venture Exchange and completing three phases of construction. OrganiGram is excited to capitalize on these achievements and execute on the business plan.
Moving forward, the company’s shareholders, patients and partners will begin to see the results from the foundation laid in 2014. To date, the company has been extremely focused on expanding the production facility while, at the same time, working to increase production levels. These efforts will begin to provide significant product to the market in March of this year. Thereafter, the utilization of the company’s existing rooms and rooms under construction will ensure that OrganiGram is poised to meet its financial goals in 2015.
OrganiGram would like to take this opportunity to congratulate Trauma Healing Centers on the opening of its first clinic, in Halifax, N.S. OrganiGram is proud to be partnered with Trauma Healing Centers on research initiatives to assist veterans and others suffering with posttraumatic stress disorder (PTSD).
OrganiGram’s chief executive officer, Denis Arsenault, states: “Over the past few months, OrganiGram has moved into a best-in-class manufacturing facility. Our processes and systems have been developed to a point where we produce high-quality products, in an organic form, which has and will continue to exceed the requirements of our clients. While we continue to evolve and improve, our facility will begin to supply the market with an established source of product on a consistent basis. We have a superior management team in place that is not only focused on supply but also quality, efficiency and product development. The results of our efforts will not only be very profitable for the company and shareholders but most importantly will provide a rapidly increasing client base with a medicinal product that assists in a much-improved quality of life for many. The developments of the next few weeks and months will be both exciting and fruitful for our company.”
We seek Safe Harbor.
- Published in Blog
Organigram (TSXV:OGI) has entered into a binding letter of intent with Trauma Healing Centers!
Organigram (TSXV:OGI) Has continued to show its innovation in the marketplace with its latest expansion.
Today, November 11th, Organigram entered into a binding LOI with Trauma Healing Centers. By June 2015 Organigram will cater to 13 new locations, including Edmonton, Ottawa, Quebec and Halifax. Medical marijuana has long been known to aid PTSD users, and this is a major step in bringing it to the public. This collaboration will bring about new research into PTSD and the use of marijuana as treatment. Organigram’s dedication the highest level of quality can easily be seen in its recent internationally recognized organic certifcation.
The current medical marijuana space has seen many turns. The recent changes in Oregon, Alaska and DC joining the legalized world of marijuana shows how new this industry is, and how quickly things are changing. We are only at the beginning of this North American emerging market! With over 1000 applications to Health Canada for licenses, Organigram’s early acceptance will allow them a strong foothold on the growing marketplace.
- Published in Blog
Van Sun urges caution on Vodis, other pot stocks
See In the News (C-VP) Vodis Pharmaceuticals Inc
The Vancouver Sun reports in its Wednesday edition reefer madness is a reasonable description of the frenzy sparked by Canada’s decision to replace 30,000 small medical marijuana producers by licensing a few big ones. The Sun’s Daphne Bramham writes eventually, the market could be worth as much as $3-billion. There has been so much hype that in June, the B.C. Securities Commission urged people to be “cautious” about investing in medical marijuana companies, most of which have yet to receive Health Canada approval. Health Canada confirms only 22 applications have been approved so far, and only three of those are publicly traded. The rest are trading on the imprimatur of big names and the hopes and dreams of all the money to be made. The licensed OrganiGram trades above $2, while the unlicensed Vodis Innovative Pharmaceuticals trades at 40 cents. Vodis recently added sitting Liberal Senator Larry Campbell to its advisory board. He is being paid in stock options — 250,000 at 40 cents. Also on the board is John Reynolds, a Conservative bagman, former speaker of the B.C. legislature, former MP and former Howe Street stock promoter. Muileboom Organics boasts former prime minister John Turner on its board.
- Published in Blog
OrganiGram ships first medical marijuana orders
ORGANIGRAM PASSES PRODUCT TESTING AND SHIPS MEDICAL MARIJUANA TO CUSTOMERS
OrganiGram Holdings Inc. has shipped its first orders of medical marijuana to customers.
The product being shipped was sent to RPC Laboratory to undergo product testing as per Health Canada guidelines. The company has received the results of said testing that confirm the product to be in conformance with the Health Canada marijuana for medical purposes regulations (MMPR).
Chief executive officer Denis Arsenault states: “We are extremely pleased to have passed testing and shipped product to our first customers. The fact that we were able to produce product that passed testing without the process of irradiation (cold pasteurization) confirms the high quality of our team, facility and validated the benefits of our organic growing process.”
d
- Published in Medical Marijuana